DE602005014393D1 - Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln - Google Patents

Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln

Info

Publication number
DE602005014393D1
DE602005014393D1 DE602005014393T DE602005014393T DE602005014393D1 DE 602005014393 D1 DE602005014393 D1 DE 602005014393D1 DE 602005014393 T DE602005014393 T DE 602005014393T DE 602005014393 T DE602005014393 T DE 602005014393T DE 602005014393 D1 DE602005014393 D1 DE 602005014393D1
Authority
DE
Germany
Prior art keywords
platinum
aqueous solvent
pharmaceutical compositions
antitumorous
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005014393T
Other languages
English (en)
Inventor
Satish Chandra Upadhyay
Manoj Kumar Pananchukunnath
Dinesh Kumar
Ajeet Kumar Singh
Rama Mukherjee
Anand C Burman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Oncology Ltd
Original Assignee
Dabur Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Pharma Ltd filed Critical Dabur Pharma Ltd
Publication of DE602005014393D1 publication Critical patent/DE602005014393D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602005014393T 2005-03-28 2005-07-05 Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln Expired - Lifetime DE602005014393D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN237KO2005 2005-03-28
PCT/IN2005/000228 WO2006103691A1 (en) 2005-03-28 2005-07-05 Stable pharmaceutical compositions of platinum (ii) antitumour agents

Publications (1)

Publication Number Publication Date
DE602005014393D1 true DE602005014393D1 (de) 2009-06-18

Family

ID=34979967

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005014393T Expired - Lifetime DE602005014393D1 (de) 2005-03-28 2005-07-05 Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln

Country Status (6)

Country Link
US (1) US20060216360A1 (de)
EP (1) EP1879568B1 (de)
AT (1) ATE430564T1 (de)
AU (1) AU2005329764B2 (de)
DE (1) DE602005014393D1 (de)
WO (1) WO2006103691A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110075507A1 (en) * 1997-10-24 2011-03-31 Revalesio Corporation Diffuser/emulsifier
US6702949B2 (en) 1997-10-24 2004-03-09 Microdiffusion, Inc. Diffuser/emulsifier for aquaculture applications
WO2007074641A1 (ja) * 2005-12-29 2007-07-05 Nipro Corporation 白金錯体を含有する水溶液医薬製剤
WO2008052145A2 (en) 2006-10-25 2008-05-02 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
JP5491185B2 (ja) 2006-10-25 2014-05-14 リバルシオ コーポレイション 傷のケアおよび処置の方法
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
US8445546B2 (en) 2006-10-25 2013-05-21 Revalesio Corporation Electrokinetically-altered fluids comprising charge-stabilized gas-containing nanostructures
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
CA2667634C (en) 2006-10-25 2016-07-12 Revalesio Corporation Mixing device and output fluids of same
CA2703672A1 (en) * 2007-10-25 2009-04-30 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
US20090263495A1 (en) * 2007-10-25 2009-10-22 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US9745567B2 (en) 2008-04-28 2017-08-29 Revalesio Corporation Compositions and methods for treating multiple sclerosis
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
WO2009134929A2 (en) 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
US9198929B2 (en) 2010-05-07 2015-12-01 Revalesio Corporation Compositions and methods for enhancing physiological performance and recovery time
BR112013003110A2 (pt) 2010-08-12 2016-06-28 Revalesio Corp composições e métodos para tratamento de taupatia
KR101508275B1 (ko) * 2011-12-16 2015-04-08 주식회사 삼양바이오팜 고분자 나노입자 수용액 조성물 및 그 제조방법
US20160375234A1 (en) * 2014-01-10 2016-12-29 Atossa Genetic Inc. Transpapillary methods and compositions for diagnosing and treating breast conditions
RU2676269C1 (ru) * 2015-04-10 2018-12-27 Син-Нат Продактс Энтерпрайз Ллс Способ получения дициклоплатина
PL3826613T3 (pl) 2018-08-31 2025-04-07 Sun Pharmaceutical Industries Limited Pozajelitowa postać dawkowania karboplatyny
US12427104B1 (en) * 2025-04-01 2025-09-30 Ingenus Pharmaceuticals, Llc Injectable carboplatin formulations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588505A5 (de) * 1972-06-08 1977-06-15 Research Corp
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
US4310515A (en) * 1978-05-30 1982-01-12 Bristol-Myers Company Pharmaceutical compositions of cisplatin
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
HU193809B (en) * 1984-09-12 1987-12-28 Chugai Pharmaceutical Co Ltd Process for producing new platinum complexes
US4915956A (en) * 1987-12-16 1990-04-10 Lyphomed, Inc. Liquid cisplatin formulations
NL8901433A (nl) * 1989-06-06 1991-01-02 Pharmachemie Bv Carboplatinpreparaat.
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
JP3154399B2 (ja) * 1996-07-04 2001-04-09 デビオファーム エス．アー． 白金化合物の製造方法
GB9804013D0 (en) * 1998-02-25 1998-04-22 Sanofi Sa Formulations
CZ292170B6 (cs) * 1998-08-14 2003-08-13 Pliva-Lachema A.S. Farmaceutická kompozice s protinádorovým účinkem na bázi carboplatiny
WO2003004505A1 (en) * 2001-07-02 2003-01-16 Debiopharm S.A. Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
JP2006342058A (ja) * 2003-06-20 2006-12-21 Otsuka Pharmaceut Factory Inc プラスチック製容器入りシスプラチン製剤

Also Published As

Publication number Publication date
US20060216360A1 (en) 2006-09-28
AU2005329764B2 (en) 2010-08-12
ATE430564T1 (de) 2009-05-15
WO2006103691A1 (en) 2006-10-05
EP1879568B1 (de) 2009-05-06
EP1879568A1 (de) 2008-01-23
AU2005329764A1 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
DE602005014393D1 (de) Stabile pharmazeutische zusammensetzungen aus antitumoralen platin-(ii)-mitteln
EA200200431A1 (ru) Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства
NO20062513L (no) Sammensetninger og doseringsformer for forsterket absorpsjon av metformin
EA200970726A1 (ru) Твердый препарат, содержащий алоглиптин и пиоглитазон
NO20071505L (no) Fremgangsmate for sammensetting av legemiddelavgivelsesanordninger.
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
NO20075136L (no) Nye liposompreparater
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
WO2008013929A3 (en) Anti-migraine oral spray formulations and methods
ATE493973T1 (de) Irbesartan enthaltende pharmazeutische zusammensetzung
CY1109366T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης
ITMI20022674A1 (it) Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
EA200601846A1 (ru) Содержащие бензоксазины лекарственные комбинации для лечения заболеваний дыхательных путей
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
ATE539761T1 (de) Mittel für injektionszwecke mit einem antibiotikum und das mittel enthaltende lösung zur injektion
DE60329968D1 (de) Dosierungsformen enthaltend Thyroidhormone und deren Herstellungsverfahren
ATE350024T1 (de) Flüssige zubereitung enthaltend tobramycin
DE602006001699D1 (de) Stabile pharmazeutische Zusammensetzung mit Linezolid Form IV
WO2006131923A3 (en) Novel salts of conjugated psychotropic drugs and processes of preparing same
DK1305057T3 (da) Mikropartikelformig biomaterialesammensætning af hyaluronsyre til medicinsk anvendelse
ATE307588T1 (de) Pharmazeutische formulierung enhaltend midazolam zur buccalen verabreichung
DE602005009110D1 (de) Injektierbare wässrige Paclitaxel-Lösungen und Verfahren zu ihrer Herstellung
ATE462419T1 (de) Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: FRESENIUS KABI ONCOLOGY LTD., NEW DEHLI, IN

8364 No opposition during term of opposition